Barclays analyst Matt Miksic lowered the firm’s price target on Bausch + Lomb (BLCO) to $16 from $19 and keeps an Equal Weight rating on the shares. The company confirmed at an investor conference that it will be able to offset its 25c tariff headwind, the analyst tells investors in a research note. The firm cut the price target but expects Bausch + Lomb to potentially trade higher in the near-term on this update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Bausch + Lomb Expands Eye Care Range with New Blink Eye Drops
- Bausch + Lomb launches Blink Nourish, Blink Boost eyedrops in U.S.
- Bausch + Lomb Shareholders Approve Executive Compensation
- Bausch + Lomb launches LUMIFY Preservative Free redness reliever eye drops in US
- Bausch + Lomb’s New Board Agreements Announced